Is a complete ENSC research report available?

No complete published report is available for Ensysce Biosciences, Inc. (ENSC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · USD

$0.26

-0.01 (-4.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ENSC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.8M
Revenue (ttm)	4.7M
Net income (ttm)	-11.8M
EPS (ttm)	-$3.01
Shares out	14.7M
Volume	363,923
Beta	0.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.7M
Net income (ttm): -11.8M
EPS (ttm): -$3.01
Market cap: 3.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ENSC indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001716947
Company name	Ensysce Biosciences, Inc.
Country	United States
Country code	US
Cusip	293602504
Employees	10
Employees Change	2%
Employees Change Percent	25
Enterprise value	$3.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US2936025046
Last refreshed	2026-07-25
Market cap	$3.8M
Market cap category	Nano-Cap
Price	$0.26
Price currency	USD
Rev Per Employee	470,787.7x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	ENSC
Website	https://www.ensysce.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-305.33%
EV Sales Forward	0.46x
EV/Sales	0.71x
FCF yield	-251.89%
P/S ratio	0.82x
PS Forward	0.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-251.4%
EBITDA Margin	-251.4%
Gross margin	-151.46%
Gross Profit	$-7.1M
Net Income	$-11.8M
Net Income Growth Years	0%
Pretax Margin	-250.37%
Profit Margin	-250.36%
Profit Per Employee	$-1.2M
ROA	-218.2
Roa5y	-127.8
ROCE	1,769.1
ROE	-1,149.1
ROIC	-579.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-88.3%
Cagr3y	-79.75%
Cagr5y	-89.93%
EPS Growth Quarters	2
EPS Growth Years	4
Revenue Growth	-24.36x
Revenue Growth Q	-27.18x
Revenue Growth Years	0x
Revenue Growth3 Y	20.21x
Revenue Growth5 Y	7.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.39
Assets	$2.2M
Cash	$745,482
Current Assets	$2M
Current Liabilities	$2.8M
Debt	$245,849
Equity	$-669,012
Interest Coverage	-628.4
Liabilities	$2.8M
Long Term Assets	$159,263
Long Term Liabilities	$0
Net Cash	$499,633
Net Cash By Market Cap	$12.94
Net Cash Growth	-82.12%
Tangible Book Value	$-340,042
Tangible Book Value Per Share	$-0.04
WACC	8.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Net Working Capital	$-1.3M
Quick ratio	0.26
Working Capital	$-828,275
Working Capital Turnover	$5.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-310.98%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-88.28%
200-day SMA	0.87
3Y total return	-99.17%
50-day SMA	0.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	86,364
All Time High Change	-100%
All Time High Date	2021-02-01
All Time Low	0.23
All Time Low Change	13.65%
All Time Low Date	2026-05-14
ATR	0.02
Beta	0.79
Beta1y	1.16
Beta2y	1.47
Ch YTD	-71.59
High	0.28
High52	2.75
High52 Date	2025-10-16
High52ch	-90.49%
Low	0.26
Low52	0.23
Low52 Date	2026-05-14
Low52ch	13.65%
Ma50ch	-7.27%
Price vs 200-day SMA	-70.08%
RSI	41.69
RSI Monthly	28.65
RSI Weekly	31.66
Sharpe ratio	-1.36x
Sortino ratio	-2.07
Total Return	-310.98%
Tr YTD	-71.59
Tr1m	-4.98%
Tr1w	-7.57%
Tr3m	-38.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.5
Earnings Revenue Estimate	1,900,000x
Earnings Revenue Estimate Growth	38.58x
Operating Income	$-11.8M
Operating margin	-251.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,684,188%
Float Percent	99.93%
Net Borrowing	-233,006
Shares Insiders	0.07%
Shares Institutions	6.12%
Shares Out	14,694,492
Shares Qo Q	85.34%
Shares Yo Y	310.98%
Short Float	1.24%
Short Ratio	0.15
Short Shares	1.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.5M
Average Volume	1,362,921.85x
Bv Per Share	-0.04
CAPEX	$-123,643
Ch1m	-4.98
Ch1w	-7.57
Ch1y	-88.28
Ch3m	-38.35
Ch3y	-99.17
Ch5y	-100
Ch6m	-69.57
Change	-4.11%
Change From Open	-3.19
Close	0.27
Days Gap	-0.95
Depreciation Amortization	13,066
Dollar Volume	95,129.5
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-11.8M
EBITDA	$-11.8M
EPS	$-3.01
F Score	2
FCF	$-9.7M
FCF EV Yield	-289.34x
FCF Per Share	$-0.66
Financing CF	7,416,439
Fiscal Year End	December
Founded	2,003
Investing CF	-123,643
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-12-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.51
Ma150ch	-48.84%
Ma20	0.28
Ma20ch	-7.63%
Net CF	-2,307,009
Next Earnings Date	2026-08-12
Open	0.27
Optionable	No
Position In Range	25.11
Post Close	0.26
Postmarket Change Percent	-0.04
Postmarket Price	$0.26
Ppne	117,596
Price Date	2026-07-24
Relative Volume	0.27x
Revenue	4,707,877x
SBC By Revenue	16.83x
Share Based Comp	792,167
Tr6m	-69.57%
Us State	California
Volume	363,923
Z Score	-107.8

Ensysce Biosciences, Inc. (ENSC)

Coverage state: Market snapshot only — no published research

Generate the first ENSC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ENSC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENSC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ENSC

Frequently asked questions